ROLE OF AMP-ACTIVATED PROTEIN KINASE IN LAFORA AND WOLFF-PARKINSON-WHITE DISEASE
AMP 激活的蛋白激酶在 Lafora 和 Wolff-Parkinson-White 病中的作用
基本信息
- 批准号:7960502
- 负责人:
- 金额:$ 25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:5&apos-AMP-activated protein kinaseAMP-activated protein kinase kinaseAffectApoptosisBindingBiochemicalCarbohydratesCellsCenters of Research ExcellenceCessation of lifeComputer Retrieval of Information on Scientific Projects DatabaseConsensusCytoplasmDiabetes MellitusDiseaseEpilepsyEventFundingGrantHeartHeart HypertrophyIn VitroInstitutionLafora DiseaseMapsMetabolic DiseasesMolecularMutationNeuronsParkinson DiseasePatientsPhosphoric Monoester HydrolasesPhosphorylationPhosphorylation SiteResearchResearch PersonnelResourcesRoleSourceTranslatingUnited States National Institutes of HealthWolff-Parkinson-White Syndromebasecarbohydrate metabolismcatalysthuman diseasein vivoinsightmouse modelnovelsensor
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Lafora disease (LD) is caused by mutations in the carbohydrate phosphatase laforin. A hallmark of LD is the accumulation of insoluble carbohyrate, called Lafora bodies (LBs), in the cytoplasm of cells. While LBs accumulate in most cells, apoptosis only occurs in neurons and this eventually leads to epilepsy and death of the patient. Wolff-Parkinson-White (WPW) syndrome is a cardiac hypertrophy caused by insoluble carbohydrate accumulations resulting from mutations in the cellular energy sensor and regulator AMP-activated protein kinase (AMPK). We recently identified both a phenotypic and biochemical connection between LD and WPW. We discovered that i) carbohyrate accumulations in LD and WPW are very similar, ii) laforin contains an AMPK consensus phosphorylation site, iii) AMPK phosphorylates laforin in vitro, and iv) carbohydrates increase AMPK kinase activity towards laforin. This proposal will define these events and determine the connection between LD and WPW. Specific Aim 1 will identify the conditions that promote phosphorylation in vivo and map the in vivo phosphorylation site(s). In specific Aim 2, we will determine if AMPK phosphorylation affects laforin binding to known substrates, the localization of laforin, and/or the phosphatase of laforin. In specific aim 3, we will determine the mechanism of carbohydrate stimulated AMPK kinase activity. In doing so, we will define the fold increase in AMPK-kinase activity, the carbohydrate(s) catalyst, and the substrates affected. Finally, we will translate these findings into a mouse model of LD. The studies proposed will define the connection between AMPK-WPW with laforin-LD. In addition, they will better characterize carbohydrate metabolism, which is at the heart of multiple metabolic disorders including diabetes, and yield insights into novel treatments.
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
拉福拉病(LD)是由碳水化合物磷酸酶拉福林突变引起的。LD的一个特点是在细胞质中积累了不溶的碳水化合物,称为拉福拉小体(Lbs)。虽然Lbs在大多数细胞中积累,但细胞凋亡只发生在神经元中,这最终会导致癫痫和患者的死亡。沃尔夫-帕金森-怀特(Wolff-Parkinson-White,WPW)综合征是一种由细胞能量感受器和调节器AMP激活的蛋白激酶(AMPK)突变引起的不溶性碳水化合物积聚引起的心肌肥厚。我们最近发现了LD和WPW之间的表型和生化联系。我们发现:1)在LD和WPW中碳水化合物的积累非常相似,2)Laforin含有AMPK共同的磷酸化位点,III)AMPK在体外使Laforin磷酸化,IV)碳水化合物增加对Laforin的AMPK激酶活性。该提案将定义这些事件,并确定LD和WPW之间的联系。特定目标1将确定促进体内磷酸化的条件并绘制体内磷酸化位点图(S)。在特定目标2中,我们将确定AMPK磷酸化是否影响Laforin与已知底物的结合、Laforin的定位和/或Laforin的磷酸酶。在具体目标3中,我们将确定碳水化合物刺激AMPK激酶活性的机制。在这样做的过程中,我们将定义AMPK-K活性的倍增、碳水化合物(S)催化剂和受影响的底物。最后,我们将把这些发现转化为LD的小鼠模型。所提出的研究将确定AMPK-WPW和Laforin-LD之间的联系。此外,他们将更好地描述碳水化合物代谢的特征,这是包括糖尿病在内的多种代谢疾病的核心,并为新的治疗方法提供见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Matthew S. Gentry其他文献
Glycogen drives tumour initiation and progression in lung adenocarcinoma
糖原驱动肺腺癌中的肿瘤起始和进展
- DOI:
10.1038/s42255-025-01243-8 - 发表时间:
2025-03-11 - 期刊:
- 影响因子:20.800
- 作者:
Harrison A. Clarke;Tara R. Hawkinson;Cameron J. Shedlock;Terrymar Medina;Roberto A. Ribas;Lei Wu;Zizhen Liu;Xin Ma;Yi Xia;Yu Huang;Xing He;Josephine E. Chang;Lyndsay E. A. Young;Jelena A. Juras;Michael D. Buoncristiani;Alexis N. James;Anna Rushin;Matthew E. Merritt;Annette Mestas;Jessica F. Lamb;Elena C. Manauis;Grant L. Austin;Li Chen;Pankaj K. Singh;Jiang Bian;Craig W. Vander Kooi;B. Mark Evers;Christine F. Brainson;Derek B. Allison;Matthew S. Gentry;Ramon C. Sun - 通讯作者:
Ramon C. Sun
Thermophilic Phosphatases and Methods for Processing Starch Using the Same
嗜热磷酸酶和使用其加工淀粉的方法
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
Matthew S. Gentry - 通讯作者:
Matthew S. Gentry
Spatial mapping of the brain metabolome lipidome and glycome
大脑代谢组、脂质组和糖组的空间映射
- DOI:
10.1038/s41467-025-59487-7 - 发表时间:
2025-05-12 - 期刊:
- 影响因子:15.700
- 作者:
Harrison A. Clarke;Xin Ma;Cameron J. Shedlock;Terrymar Medina;Tara R. Hawkinson;Lei Wu;Roberto A. Ribas;Shannon Keohane;Sakthivel Ravi;Jennifer L. Bizon;Sara N. Burke;Jose Francisco Abisambra;Matthew E. Merritt;Boone M. Prentice;Craig W. Vander Kooi;Matthew S. Gentry;Li Chen;Ramon C. Sun - 通讯作者:
Ramon C. Sun
APOE4 Lowers Energy Expenditure and Impairs Glucose Oxidation by Increasing Flux through Aerobic Glycolysis
APOE4 通过有氧糖酵解增加通量来降低能量消耗并损害葡萄糖氧化
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
Brandon C Farmer;Holden C. Williams;Nicholas A. Devanney;Margaret A. Piron;Grant K. Nation;D. J. Carter;Adeline E. Walsh;R. Khanal;L. Young;J. Kluemper;Gabriela Hernandez;Elizabeth J. Allenger;R. Mooney;J. Anthony Brandon;Vedant A. Gupta;Philip A. Kern;Matthew S. Gentry;Josh M. Morganti;Ramon C. Sun;Lance A. Johnson - 通讯作者:
Lance A. Johnson
Spatial Metabolome Lipidome and Glycome from a Single brain Section
来自单个脑切片的空间代谢组脂质组和糖组
- DOI:
10.1101/2023.07.22.550155 - 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Harrison A. Clarke;Xin Ma;Cameron J. Shedlock;Terrymar Medina;Tara R Hawkinson;L. Wu;Roberto A. Ribas;Shannon B Keohane;Sakthivel Ravi;Jennifer L. Bizon;Sara N. Burke;J. Abisambra;Matthew E. Merritt;B. Prentice;C. V. Vander Kooi;Matthew S. Gentry;Li Chen;Ramon C. Sun - 通讯作者:
Ramon C. Sun
Matthew S. Gentry的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Matthew S. Gentry', 18)}}的其他基金
Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis
肺腺癌肿瘤发生中的异常糖原
- 批准号:
10644000 - 财政年份:2022
- 资助金额:
$ 25万 - 项目类别:
Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis
肺腺癌肿瘤发生中的异常糖原
- 批准号:
10748000 - 财政年份:2022
- 资助金额:
$ 25万 - 项目类别:
Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis
肺腺癌肿瘤发生中的异常糖原
- 批准号:
10518440 - 财政年份:2022
- 资助金额:
$ 25万 - 项目类别:
Brain Glycogen - Metabolism, Mechanisms, and Therapeutic Potential
脑糖原 - 代谢、机制和治疗潜力
- 批准号:
10285469 - 财政年份:2021
- 资助金额:
$ 25万 - 项目类别:
Brain Glycogen - Metabolism, Mechanisms, and Therapeutic Potential
脑糖原 - 代谢、机制和治疗潜力
- 批准号:
10610572 - 财政年份:2020
- 资助金额:
$ 25万 - 项目类别:
Brain Glycogen - Metabolism, Mechanisms, and Therapeutic Potential
脑糖原 - 代谢、机制和治疗潜力
- 批准号:
10786602 - 财政年份:2020
- 资助金额:
$ 25万 - 项目类别:
Brain Glycogen - Metabolism, Mechanisms, and Therapeutic Potential
脑糖原 - 代谢、机制和治疗潜力
- 批准号:
10401225 - 财政年份:2020
- 资助金额:
$ 25万 - 项目类别:
Brain Glycogen - Metabolism, Mechanisms, and Therapeutic Potential
脑糖原 - 代谢、机制和治疗潜力
- 批准号:
10405662 - 财政年份:2020
- 资助金额:
$ 25万 - 项目类别:
Brain Glycogen - Metabolism, Mechanisms, and Therapeutic Potential
脑糖原 - 代谢、机制和治疗潜力
- 批准号:
10159325 - 财政年份:2020
- 资助金额:
$ 25万 - 项目类别:
Brain Glycogen-Metabolism,Mechanisms, and Therapeutic Potential
脑糖原代谢、机制和治疗潜力
- 批准号:
10730778 - 财政年份:2020
- 资助金额:
$ 25万 - 项目类别:
相似海外基金
Pharmacological targeting of AMP-activated protein kinase for immune cell regulation in Type 1 Diabetes
AMP 激活蛋白激酶对 1 型糖尿病免疫细胞调节的药理学靶向
- 批准号:
2867610 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别:
Studentship
Establishing AMP-activated protein kinase as a regulator of adipose stem cell plasticity and function in health and disease
建立 AMP 激活蛋白激酶作为脂肪干细胞可塑性和健康和疾病功能的调节剂
- 批准号:
BB/W009633/1 - 财政年份:2022
- 资助金额:
$ 25万 - 项目类别:
Fellowship
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2021
- 资助金额:
$ 25万 - 项目类别:
Postdoctoral Fellowships
Metabolic control of integrin membrane traffic by AMP-activated protein kinase controls cell migration.
AMP 激活的蛋白激酶对整合素膜运输的代谢控制控制着细胞迁移。
- 批准号:
459043 - 财政年份:2021
- 资助金额:
$ 25万 - 项目类别:
Studentship Programs
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2020
- 资助金额:
$ 25万 - 项目类别:
Postdoctoral Fellowships
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
- 批准号:
10561642 - 财政年份:2019
- 资助金额:
$ 25万 - 项目类别:
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2019
- 资助金额:
$ 25万 - 项目类别:
Postdoctoral Fellowships
Treating Diabetic Inflammation using AMP-Activated Protein Kinase Activators
使用 AMP 激活的蛋白激酶激活剂治疗糖尿病炎症
- 批准号:
2243045 - 财政年份:2019
- 资助金额:
$ 25万 - 项目类别:
Studentship
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
- 批准号:
10359032 - 财政年份:2019
- 资助金额:
$ 25万 - 项目类别:
Investigating the therapeutic potential of AMP-activated protein kinase in myotonic dystrophy type 1
研究 AMP 激活蛋白激酶在 1 型强直性肌营养不良中的治疗潜力
- 批准号:
428988 - 财政年份:2019
- 资助金额:
$ 25万 - 项目类别:
Studentship Programs